Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.
Guillermo Garcia-ManeroGhulam J Mufti ObePierre FenauxRena J BucksteinValeria SantiniMaria Diez CampeloCarlo FinelliOsman IlhanMikkael A SekeresAmer M ZeidanRodrigo ItoJennie ZhangAnita RampersadDaniel SinsimerJay T BackstromUwe PlatzbeckerRami S KomrokjiPublished in: Blood (2021)